Analysis of conflicts of interest in pharmaceutical payments made to Food and Drug Administration physician advisers after dermatologic drug approval

被引：1

作者：

Kuschel, Stephanie L. ^{[1
]}

Ricotti, Claudia M. ^{[2
]}

Dunnick, Cory A. ^{[3
,4
]}

Hugh, Jeremy ^{[3
,4
]}

Dellavalle, Robert P. ^{[3
,4
]}

机构：

[1] Indiana Univ, Sch Med, Indianapolis, IN USA

[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA

[3] Univ Colorado, Sch Med, Aurora, CO USA

[4] Rocky Mt Reg VA Med Ctr, Dermatol Serv, 1700 N Wheeling St,Room E1-342, Aurora, CO 80045 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 06期

关键词：

D O I：

10.1016/j.jaad.2019.05.059

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1419 / 1420

页数：3

共 5 条

[1]

Lo B., 2009, Lo, B., Field, M., (2009), National Institutes of Health. Publication of clinical trials in JAMA study. 2008. Retrieved from: opasi.nih.gov/.../Final-Report-Conflict-Interest-(08-6002-OD-OER)-9-18-0...

[2] Financial conflict of interest disclosure and voting patterns at food and drug administration drug advisory committee meetings [J].

Lurie, P ;

Almeida, CM ;

Stine, N ;

Stine, AR ;

Wolfe, SM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (16) :1921-1928

[3] Revisiting Financial Conflicts of Interest in FDA Advisory Committees [J].

Pham-Kanter, Genevieve .

MILBANK QUARTERLY, 2014, 92 (03) :446-470

[4]

Piller C, 2018, SCIENCE, V361, P17

[5]

US Food and Drug Administration, 2008, GUID PUBL FDA ADV CO

← 1 →